Your session is about to expire
← Back to Search
Homeopathic Medicine
Homeopathic Treatment of Post-acute COVID-19 Syndrome
Phase 3
Waitlist Available
Led By Elizabeth Rice, ND
Research Sponsored by Southwest College of Naturopathic Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4, 8 and 12 weeks
Awards & highlights
Pivotal Trial
Summary
This trial aims to see if homeopathic medicine can help improve fatigue and quality of life for patients with Post-acute COVID-19 Syndrome. The treatment uses tiny amounts of natural substances to stimulate the body's healing. Researchers hope to gather enough data to justify a larger study.
Eligible Conditions
- Post-COVID Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4, 8 and 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4, 8 and 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Fatigue Assessment Scale (FAS)
SF-36 Mental Composite Score (MCS)
SF-36 Physical Composite Score (PCS)
Secondary study objectives
Measure Yourself Medical Outcomes Profile Symptom #1
Measure Yourself Medical Outcomes Profile Symptom #2
Patient Doctor Depth of Relationship (PDDR)
+1 moreSide effects data
From 2022 Phase 3 trial • 77 Patients • NCT051047493%
Urinary Tract Infection
3%
Musculoskeletal Pain
3%
Headache
3%
Upper Respiratory Tract Infection
3%
Vaccine Injury
3%
Insomnia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Homeopathic Treatment Group
Placebo Group
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Homeopathic Treatment GroupExperimental Treatment1 Intervention
Individualized homeopathic medicines on impregnated lactose pellets will be prescribed to each participant based on the totality of their physical, emotional, and mental symptoms. All medicines prescribed are listed in the Homeopathic Pharmacopoeia of the United States (HPUS) as outlined in the Food, Drug, and Cosmetics Act of 1939
Group II: Placebo GroupPlacebo Group1 Intervention
Identical lactose pellets in size, odor, and taste without the impregnated homeopathic medicines.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Homeopathic Medication
2016
Completed Phase 3
~140
Find a Location
Who is running the clinical trial?
Southwest College of Naturopathic MedicineLead Sponsor
5 Previous Clinical Trials
308 Total Patients Enrolled
Samueli Institute for Information BiologyOTHER
24 Previous Clinical Trials
2,425 Total Patients Enrolled
Elizabeth Rice, NDPrincipal InvestigatorSouthwest College of Naturopathic Medicine